Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Epilepsy
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Epilepsy
    Not All Epilepsy Drugs Linked to Increased Risk of Suicidal Behaviour - (DGNews)
    TopAbstracts in Epilepsy 07/22/2010 - (DGNews)
    TopAbstracts in Epilepsy 07/08/2010 - (DGNews)
    Adjunctive Eslicarbazepine Acetate Well Tolerated in Adults With Refractory Partial Seizures: Presented at ECE (Epilepsy) - (DGDispatch)
    Lacosamide Demonstrates Long-Term, Sustained Efficacy in Patients With Partial-Onset Seizures: Presented at ECE (Epilepsy) - (DGDispatch)

    News archive

     Recent webcasts/CME - Epilepsy
    • Improving Epilepsy Management Throughout the Disease Continuum
    • Case in Point: Evidence-Based Insights For Epilepsy Management - Comorbid Depressive Disorders in Epilepsy
      Case in Point: Evidence-Based Insights For Epilepsy Management - Pharmacologic Treatment of Epilepsy
      Generalized Convulsive Status Epilepticus Guillain Barre Syndrome

      Webcasts/CME archive

       Recent cases - Epilepsy
        B Cell Aplasia and Hypogammaglobulinemia after Carbamazepine Treatment
        Acute Pancreatitis Associated to the Use of Valproic Acid
        Diarrhea, Negative T-Waves, Fever and Skin Rash, Rare Manifestation of Carbamazepine Hypersensitivity: A Case Report
        Syncope Due to Asystole During Epilepsy. A Case Report
        Lennox Gastaut Syndrome, Review of the Literature and a Case Report

        Cases archive
          




        my personal edition > epilepsy > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Patients with Epilepsy More Vulnerable to Behavioral Side Effects Than People with Other Brain Disorders

        NEW HAVEN, CT -- May 29, 2003 -- Patients with epilepsy may be more likely to experience treatment-related behavioral side effects than patients receiving the same drug for other brain disorders, according to a 4,179-patient case review by a Yale School of Medicine researcher published in the May issue of the journal, Epilepsy and Behavior.

        The review compared behavioral side effects such as anxiety, depression or moodiness in patients with epilepsy being treated with an antiepileptic drug (AED) versus patients receiving the same drug to treat anxiety and cognitive disorders.

        "We have found an underlying susceptibility to behavioral side effects linked to epilepsy itself, not caused by any particular antiepileptic drug," said Joyce Cramer, lead investigator of the study and associate research scientist in the Department of Psychiatry. "AEDs continue to be a useful tool to treat epilepsy because such side effects occur in few patients overall, but what this research has really done is provide us with new insight into the way people with epilepsy respond to drugs."

        Approximately 2.3 million Americans suffer from epilepsy, which is more common worldwide than Alzheimer's disease. Epilepsy is a chronic disorder causing recurrent seizures, which are disturbances in the normal electrical function of the brain.

        The review analyzed behavioral adverse events occurring among adults receiving levetiracetam or placebo in short-term, placebo-controlled studies of epilepsy, cognitive disorders or anxiety disorders, as well as epilepsy patients observed in long-term trials. Behavioral side effects were significantly more common among patients with epilepsy than cognition or anxiety patients treated for similar durations.

        "Levetiracetam was evaluated for this study because of the large database of placebo-controlled trials available," said Cramer. "However, based on an evaluation of product labels, we found that all AEDs have the potential for increasing behavioral side effects in some patients. More research is needed."


        SOURCE: Ketchum



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send